Bayer’s Nubeqa Ameliorate Endurance in Prostate Cancer Clinical Trial
Summary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
Summary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+– ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is…
KEYPOINTS: Pfizer Inc allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low- and middle-income countries. This will be…
SYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company is hoping will bolster its pharma portfolio…
SUMMARY: Janssen’s ICEBERG study has demonstrated that Esketamine nasal spray (NS) has shown improved outcomes in an indirect treatment comparison with other…
KEYPOINTS; Antengene Corporation Limited announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for…
Novartis says that the U.S. and European regulators have accepted its marketing applications for CAR-T cell therapy Kymriah (Tisagenlecleucel) as third-line therapy…
Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…
Synopsis– The chemotherapy has been developed from a molecule found in Himalayan caterpillar fungus and is still in the experimental testing stages. The…